Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 10 Dec 2024

HDC downregulation induced by chronic stress promotes ovarian cancer progression via the IL-6/STAT3/S100A9 pathway

in Pharmacology of Anti-Cancer Drugs

Zhicong Chen
Jinming Cao
Zhijun Xiao
Zhen Yang
Yuanchi Cheng
Jingjing Duan
Ting Zhou
Feng Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485885

1,528 views

Editorial

Published on 09 Dec 2024

Editorial: Genomic discoveries and pharmaceutical development in urologic tumors

in Pharmacology of Anti-Cancer Drugs

Jialin Meng
Huan Yang
Lei Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1508979

536 views

Original Research

Published on 06 Dec 2024

Characterizing ADRs of Enfortumab vedotin and Erdafitinib in bladder cancer treatment: a descriptive analysis from WHO-VigiAccess

in Pharmacology of Anti-Cancer Drugs

Yuanbin Huang
Meiqi Xu
Xinmiao Ma
Wei Wang
Chen Shen
Fei Liu
Zhiqi Chen
Jiawen Wang
Qian Guo
Xiancheng Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503154

1,404 views
1 citation

Systematic Review

Published on 06 Dec 2024

Efficacy and safety of TACE combined with traditional Chinese medicine versus TACE alone in hepatocellular carcinoma: bayesian network meta-analysis and pharmacological mechanisms study

in Pharmacology of Anti-Cancer Drugs

Li Chen
Xiu-Ling Zhu
Jie Lin
Dong-Liang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1495343

1,545 views

Systematic Review

Published on 05 Dec 2024

Interventions for prevention and treatment of trastuzumab-induced cardiotoxicity: an umbrella review of systematic reviews and meta-analyses

in Pharmacology of Anti-Cancer Drugs

Yunfang Wang
Jianguo Xu
Yafei Xie
Dan Zhou
Mingyue Guo
Yu Qin
Kang Yi
Jinhui Tian
Tao You

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1479983

1,609 views
2 citations

Mini Review

Published on 04 Dec 2024

Fyn, an important molecule in the brain, is a potential therapeutic target for brain tumours

in Pharmacology of Anti-Cancer Drugs

Chongxi Xu
Yi Tang
Xing Lu
Ruiqi Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485919

897 views

Case Report

Published on 04 Dec 2024

Pemigatinib combined with immunotherapy and stereotactic body radiation therapy for FGFR2 fusion-positive advanced intrahepatic cholangiocarcinoma with brain metastasis: a Case Report

in Pharmacology of Anti-Cancer Drugs

Jiamin Guo
Lingqi Sun
Ye Chen
Ji Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1509891

1,257 views
2 citations

Review

Published on 04 Dec 2024

Recent advances in cell membrane-coated porphyrin-based nanoscale MOFs for enhanced photodynamic therapy

in Pharmacology of Anti-Cancer Drugs

Yutao Zou
Junjie Wu
Qiuyun Zhang
Jiayi Chen
Xuanxuan Luo
Yijie Qu
Rui Xia
Weiqi Wang
Xiaohua Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1505212

1,050 views
3 citations

Original Research

Published on 04 Dec 2024

Polyketides and alkaloids from the fungus Aspergillus Fumigatus YB4-17 and ent-Fumiquinazoline J induce apoptosis, paraptosis in human hepatoma HepG2 cells

in Pharmacology of Anti-Cancer Drugs

Huannan Wang
Lixiang Sun
Xueyang Ma
Shihao Jin
Yidan Xi
Chunmei Sai
Maocai Yan
Zhongbin Cheng
Zhen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1487977

689 views

Review

Published on 03 Dec 2024

Enhancing cancer therapy: advanced nanovehicle delivery systems for oridonin

in Pharmacology of Anti-Cancer Drugs

Yilin Su
Lisha Liu
Chongyang Lin
Dashi Deng
Yunfei Li
Mou Huang
Yu Wang
Kangqiu Ling
Haobing Wang
Qiyu Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476739

1,073 views
1 citation

Review

Published on 03 Dec 2024

Targeting cuproptosis with nano material: new way to enhancing the efficacy of immunotherapy in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Xiangdong Liu
Wanqiu Zhang
Shaozhong Wei
Xinjun Liang
Bo Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1451067

2,131 views
1 citation

Review

Published on 29 Nov 2024

Application of nanotechnology in the treatment of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Liu Cai
Yanyuan Du
Hongtai Xiong
Honggang Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438819

2,143 views
1 citation

Case Report

Published on 29 Nov 2024

Case report: Favorable efficacy of combined afatinib and anlotinib treatment in a lung adenocarcinoma patient harboring uncommon EGFR L858M/L861R mutations

in Pharmacology of Anti-Cancer Drugs

Yueming He
Yitao Wu
Rongqi He
Meng Xu
Heshan Chen
Yiran Meng
Liuqing Zheng
Li Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1437086

749 views

Review

Published on 29 Nov 2024

MiRNAs function in the development of resistance against doxorubicin in cancer cells: targeting ABC transporters

in Pharmacology of Anti-Cancer Drugs

Xin-Yan Lu
Hongxu Jin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486783

1,112 views

Case Report

Published on 28 Nov 2024

Case Report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression

in Pharmacology of Anti-Cancer Drugs

Hejing Bao
Jiani Zhang
Yuhuan Wang
Zhiting Chen
Xi Luo
Ting Li
Haoran Su
Hehong Bao
Xiaolong Cao
Liping Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448291

908 views
1 citation

Original Research

Published on 28 Nov 2024

Cepharanthine as an effective small cell lung cancer inhibitor: integrated insights from network pharmacology, RNA sequencing, and experimental validation

in Pharmacology of Anti-Cancer Drugs

Fengyun Zhao
Zhaowei Ding
Mengting Chen
Mingfang Ji
Fugui Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1517386

1,381 views